1. @entity369 - @entity5209 and @entity7222 - @entity492 solutions have been infused intravenously to @entity1 of two families. Three @entity1 of the WOL. family are affected with @entity12842 and @entity3263 , due to a lack of arginase. They present a secondary cystine- @entity68767 . The three WIL. siblings are suffering from @entity2421 , @entity4241 , @entity8 and primary @entity8324 . 2. The aim was to verify how and to what extent the artificial rise of one serum @entity535 could influence the serum concentrations and the urinary losses of the other @entity1522 . The results found for the serum have been submitted to a statistical analysis of variance. 3. The variations observed for the @entity1522 of the @entity1133 cycle can be interpreted as being the reflections of known metabolic pathways. 4. Additional remarks are made on a paradox in the lysinemia- @entity68767 relation after @entity369 infusion, with a simultaneous rise of this essential @entity535 in serum and urine.

Intravenous loading with @entity369 - @entity5209 and @entity7222 - XXXX in siblings of two families, presenting a familial neurological syndrome associated with @entity8324 .

@entity1 :: ('9606', 'Species') :: ['children'] @entity12842 :: ('MESH:D020162', 'Disease') :: ['hyperargininemia'] @entity8 :: ('MESH:D007674', 'Disease') :: ['incomplete renal tubular acidosis'] @entity1522 :: ('CHEBI:33709', 'Chemical') :: ['amino acids'] @entity8324 :: ('MESH:D003555', 'Disease') :: ['cystinuria'] @entity1133 :: ('MESH:D014508', 'Chemical') :: ['urea'] @entity535 :: ('CHEBI:33704', 'Chemical') :: ['amino acid'] @entity7222 :: ('CHEBI:18257', 'Chemical') :: ['ornithine'] @entity4241 :: ('MESH:D004392', 'Disease') :: ['dwarfism'] @entity68767 :: ('MESH:C565630', 'Disease') :: ['lysinuria'] @entity2421 :: ('MESH:D009123', 'Disease') :: ['muscular hypotonia'] @entity492 :: ('CHEBI:29995', 'Chemical') :: ['aspartate'] @entity5209 :: ('CHEBI:36807', 'Chemical') :: ['hydrochloride'] @entity369 :: ('CHEBI:29016', 'Chemical') :: ['arginine', 'Arginine'] @entity3263 :: ('MESH:D022124', 'Disease') :: ['hyperammonemia']
@entity492 :: (CHEBI:29995,Chemical) :: ['aspartate']
